This September marks 40 years since the birth of the generic drug industry in the United States. They saved Americans nearly $450 billion last year alone. But all is not well in the industry — big players are leaving, and drug shortages are common. Will we still be able to depend on affordable, high-quality generics in the future? Also: new rules on bank mergers, and a disagreement between the stock market and bond market.